PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-1.82%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$959M
AUM Growth
+$959M
(-28%)
Cap. Flow
-$282M
Cap. Flow
% of AUM
-29.37%
Top 10 Holdings %
Top 10 Hldgs %
47.31%
Holding
279
New
35
Increased
32
Reduced
64
Closed
57
Top Buys
| 1 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$16.9M |
| 2 |
VRAY
ViewRay, Inc.
VRAY
|
$16.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$15M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$14.3M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
$12.8M |
Top Sells
| 1 |
Seer Inc
SEER
|
$29.6M |
| 2 |
WM Technology
MAPS
|
$23.4M |
| 3 |
LivaNova
LIVN
|
$21.2M |
| 4 |
Glaukos
GKOS
|
$18.2M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$17.5M |
Sector Composition
| 1 | Healthcare | 85.74% |
| 2 | Consumer Staples | 1.68% |
| 3 | Financials | 1.43% |
| 4 | Consumer Discretionary | 1.22% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procept Biorobotics
PRCT
$2.11B
| $3.88M | 0.14% |
155,214
-4,786
| -3% | -$120K |
|
52
Incyte
INCY
$17B
| $3.62M | 0.13% |
+49,278
| New | +$3.62M |
|
53
Travere Therapeutics
TVTX
$1.75B
| $3.41M | 0.12% |
109,925
+56,135
| +104% | +$1.74M |
|
|
APEN
54
DELISTED
Apollo Endosurgery, Inc.
APEN
| $3.16M | 0.11% |
+374,657
| New | +$3.16M |
|
|
BLU
55
DELISTED
BELLUS Health Inc.
BLU
| $3.12M | 0.11% |
387,797
+52,992
| +16% | +$427K |
|
56
Rapid Micro Biosystems
RPID
$105M
| $2.95M | 0.11% |
276,871
-55,265
| -17% | -$588K |
|
57
Arcutis Biotherapeutics
ARQT
$1.91B
| $2.88M | 0.1% |
138,663
+26,339
| +23% | +$546K |
|
58
BioNTech
BNTX
$24.1B
| $2.54M | 0.09% |
+9,857
| New | +$2.54M |
|
59
Adicet Bio
ACET
$60.8M
| $2.39M | 0.09% |
+136,808
| New | +$2.39M |
|
60
United Therapeutics
UTHR
$17.7B
| $2.33M | 0.08% |
10,758
+2,171
| +25% | +$469K |
|
|
ARNA
61
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.26M | 0.08% |
24,361
+4,361
| +22% | +$405K |
|
62
Lyra Therapeutics
LYRA
$11.8M
| $2.26M | 0.08% |
517,244
-16,173
| -3% | -$70.4K |
|
63
Viridian Therapeutics
VRDN
$1.59B
| $2.07M | 0.08% |
104,860
+46,764
| +80% | +$924K |
|
64
Phathom Pharmaceuticals
PHAT
$843M
| $2M | 0.07% |
101,728
+69,153
| +212% | +$1.36M |
|
65
Merus
MRUS
$5.04B
| $1.87M | 0.07% |
+58,660
| New | +$1.87M |
|
66
Merck
MRK
$210B
| $1.86M | 0.07% |
24,246
-60,754
| -71% | -$4.66M |
|
|
IMGN
67
DELISTED
Immunogen Inc
IMGN
| $1.85M | 0.07% |
249,283
-93,765
| -27% | -$696K |
|
68
Universe Pharmaceuticals
UPC
$2.11M
| $1.82M | 0.07% |
1,115,085
+847,126
| +316% | +$1.39M |
|
|
SNAX
69
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
| $1.73M | 0.06% |
437,551
-137,449
| -24% | -$543K |
|
|
DALS
70
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $1.62M | 0.06% |
164,834
-35,166
| -18% | -$345K |
|
|
PMGMU
71
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
| $1.56M | 0.06% |
157,759
-1,709
| -1% | -$16.9K |
|
|
SRRA
72
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.55M | 0.06% |
71,320
-2,313
| -3% | -$50.3K |
|
73
Xenon Pharmaceuticals
XENE
$2.99B
| $1.52M | 0.05% |
48,502
-1,498
| -3% | -$46.8K |
|
|
BHVN
74
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.5M | 0.05% |
+10,885
| New | +$1.5M |
|
75
Ionis Pharmaceuticals
IONS
$9.64B
| $1.48M | 0.05% |
+48,544
| New | +$1.48M |
|